Tickers

1. Composite Trajectory Verdict

The income statement carries the most weight for assessing RPAY's financial performance because its payment-processing model generates revenue from transaction volumes while carrying high fixed amortization and goodwill from acquisitions, making GAAP profitability and impairment trends the primary signal of whether the embedded client base is sustaining value.

Composite Trajectory: Mixed

Annual GAAP results deteriorated sharply in 2025, with net loss widening to $(271.1)M from $(10.3)M in 2024 driven by a $242.7M goodwill impairment (10-K 2025-12-31, Consolidated Statements of Operations). Revenue declined 1.2% to $309.3M (10-K 2025-12-31, Consolidated Statements of Operations). Operating cash flow fell 39% to $91.1M from $150.1M (10-K 2025-12-31, Consolidated Statements of Cash Flows). Quarterly trends show improvement: H1 2026 revenue rose 18.6% to $181.5M vs H1 2025 (10-Q 2026-06-30, MD&A), net loss narrowed to $(21.6)M from $(116.2)M (10-Q 2026-06-30, Condensed Statements of Operations), and operating cash flow increased to $57.1M from $35.6M (10-Q 2026-06-30, Condensed Statements of Cash Flows). However, Adjusted Net Income (non-GAAP) declined 5.3% in H1 2026 to $37.3M (10-Q 2026-06-30, Reconciliation). Balance sheet weakened: cash dropped to $83.7M at June 30, 2026 from $115.7M at Dec 31, 2025 (10-Q 2026-06-30, MD&A; 10-K 2025-12-31, Consolidated Balance Sheets), and goodwill fell to $474.5M from $716.8M (10-K 2025-12-31, Consolidated Balance Sheets).

2. Red Flags

• GAAP net loss widened 2,523% YoY in 2025 to $(271.1)M vs $(10.3)M in 2024, almost entirely from a $242.7M goodwill impairment (10-K 2025-12-31, Consolidated Statements of Operations; MD&A).
• Operating cash flow declined 39% YoY to $91.1M in 2025 from $150.1M in 2024 (10-K 2025-12-31, Consolidated Statements of Cash Flows).
• Cash and cash equivalents fell 39% to $115.7M at Dec 31, 2025 from $189.5M at Dec 31, 2024, and further to $83.7M at June 30, 2026 (10-K 2025-12-31, Consolidated Balance Sheets; 10-Q 2026-06-30, MD&A).
• Goodwill impaired by $242.3M in 2025 ($241.7M Consumer Payments, $0.6M Business Payments), reducing total goodwill to $474.5M from $716.8M (10-K 2025-12-31, Note 9 Goodwill).
• Current maturities of long-term debt jumped to $146.5M at Dec 31, 2025 from $0 at Dec 31, 2024, reflecting the 2026 Notes reclassification (10-K 2025-12-31, Consolidated Balance Sheets).
• Interest expense nearly doubled to $13.9M in 2025 from $7.9M in 2024 (10-K 2025-12-31, Consolidated Statements of Operations).
• Adjusted EBITDA (non-GAAP) declined 8.7% to $128.6M in 2025 from $140.8M in 2024 (10-K 2025-12-31, Reconciliation).
• TRA liability remains large at $200.9M (Level 3 fair value) with $13.5M fair value loss in 2025 (10-K 2025-12-31, Note 6; Consolidated Statements of Operations).
• Share count declined (basic shares 85.6M in 2025 vs 89.9M in 2024) due to $38.3M of repurchases while GAAP losses mounted (10-K 2025-12-31, Consolidated Statements of Operations; MD&A).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual GAAP revenue was essentially flat, declining 1.2% to $309.3M in 2025 from $313.0M in 2024 (10-K 2025-12-31, Consolidated Statements of Operations). GAAP net loss deteriorated to $(271.1)M from $(10.3)M, driven by a $242.7M impairment loss (10-K 2025-12-31, Consolidated Statements of Operations). Gross profit margin compressed to 75% from 77% (10-K 2025-12-31, MD&A Segments table). Quarterly trends reversed: H1 2026 revenue grew 18.6% to $181.5M vs H1 2025 (10-Q 2026-06-30, MD&A), and net loss narrowed to $(21.6)M from $(116.2)M (10-Q 2026-06-30, Condensed Statements of Operations). However, H1 2026 Adjusted Net Income (non-GAAP) fell 5.3% to $37.3M (10-Q 2026-06-30, Reconciliation). Consumer Payments segment revenue grew 1.8% annually to $285.9M but Business Payments fell 8.5% to $48.4M (10-K 2025-12-31, MD&A Segments). In H1 2026, Consumer Payments revenue rose 18.5% to $168.8M and Business Payments rose 25.1% to $27.5M, both aided by the KUBRA acquisition (~$20.8M incremental revenue) (10-Q 2026-06-30, MD&A Segments).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Annual operating cash flow declined 39% to $91.1M in 2025 from $150.1M in 2024 (10-K 2025-12-31, Consolidated Statements of Cash Flows). Free cash flow (operating minus capitalized software) was approximately $49.6M in 2025 ($91.1M - $41.5M) vs $105.2M in 2024 ($150.1M - $44.9M) (10-K 2025-12-31, Consolidated Statements of Cash Flows). Cash used in financing activities surged to $130.2M in 2025 from $12.7M in 2024, driven by $72.0M of 2026 Notes repurchases, $38.5M of share repurchases, and $16.3M TRA payment (10-K 2025-12-31, Consolidated Statements of Cash Flows). H1 2026 operating cash flow improved to $57.1M from $35.6M in H1 2025 (10-Q 2026-06-30, Condensed Statements of Cash Flows), but cash and equivalents fell to $83.7M at June 30, 2026 from $115.7M at Dec 31, 2025 (10-Q 2026-06-30, MD&A; 10-K 2025-12-31, Consolidated Balance Sheets). The company drew $110M on its revolver in January 2026 to repay the remaining 2026 Notes (10-K 2025-12-31, Note 16 Subsequent Events).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Total assets declined 24% to $1.20B at Dec 31, 2025 from $1.57B at Dec 31, 2024 (10-K 2025-12-31, Consolidated Balance Sheets). Goodwill fell 34% to $474.5M from $716.8M due to $242.3M of impairments (10-K 2025-12-31, Consolidated Balance Sheets; Note 9). Intangible assets declined 15% to $329.8M from $389.0M (10-K 2025-12-31, Consolidated Balance Sheets). Cash and equivalents dropped 39% to $115.7M from $189.5M (10-K 2025-12-31, Consolidated Balance Sheets). Total liabilities fell 10% to $718.0M from $798.7M, primarily from $216.7M reduction in long-term debt (current + non-current) as 2026 Notes were repurchased and reclassified (10-K 2025-12-31, Consolidated Balance Sheets). Stockholders' equity fell 36% to $484.4M from $761.3M, driven by the $256.7M net loss attributable to the Company and $38.5M of treasury stock repurchases (10-K 2025-12-31, Consolidated Balance Sheets; Consolidated Statements of Changes in Equity). At June 30, 2026, cash further declined to $83.7M with $100M revolver availability (10-Q 2026-06-30, MD&A).

6. Data Gaps

• Stand-alone Q2 2026 and Q1 2026 GAAP revenue, gross profit, and operating expense breakdowns (10-Q provides only H1 and Q2 comparisons; Q1 2026 standalone not separately disclosed)
• Annual 2026 full-year guidance or trajectory (only H1 2026 reported)
• Organic revenue growth rate excluding KUBRA acquisition for H1 2026 (filing discloses ~$20.8M incremental KUBRA revenue but not organic growth %)
• Q2 2026 and H1 2026 capitalized software development costs (10-Q cash flow statement truncated)
• Q2 2026 ending goodwill and intangible balances (10-Q balance sheet not provided in excerpt)
• Detailed debt maturity schedule beyond 2026-2029 for the revolving credit facility and Term Loan Facility mentioned in 10-Q (10-Q 2026-06-30, MD&A references Term Loan Facility not detailed in 10-K)
• Segment-level operating expenses and operating income for quarterly periods (10-Q provides only revenue and gross profit by segment)